NCT02890966View on ClinicalTrials.gov

Multiple Dose Study of SHR4640 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Gout; Hyperuricemia
Interventions
DRUG

SHR4640

Day1\~Day7:oral administration

DRUG

placebo

Day1\~Day7:oral administration

Trial Locations (1)

400042

The South West Hospital, Chongqing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02890966 - Multiple Dose Study of SHR4640 in Healthy Subjects | Biotech Hunter | Biotech Hunter